Cambridge Photon Technology is attempting to commercialize a photon multiplication technology that splits high energy photons to increase usable light for silicon cells. The UK-based startup has three ...

ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...

Stress affects many systems in our body and biologists Marcel Schaaf and Erin Faught at Radboud University are figuring out ...

The world’s supply of many life-saving medications depends on people in the United States deciding to sell their blood plasma ...

STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

Cervical cancer usually does not cause symptoms until it is advanced. A new guideline makes it easier to detect when ...

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

Every day habits and experiences can speed up your cells' aging process, making your body and mind older than your actual age ...

Study links anxiety to 74% fewer natural killer cells—immune defenders against cancer and infections. Insomnia intensifies ...

NYU Langone researchers found that blocking a single protein in the body can trigger a form of self-destruction in lung ...

A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...